Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 210.12 million compared to CNY 225.63 million a year ago. Revenue was CNY 210.12 million compared to CNY 225.63 million a year ago.

Net income was CNY 31.15 million compared to CNY 21.56 million a year ago. Basic earnings per share from continuing operations was CNY 0.3 compared to CNY 0.24 a year ago. Diluted earnings per share from continuing operations was CNY 0.3 compared to CNY 0.23 a year ago.